BioAtla: Numerous Catalysts Coming In Q4

The cancer-focused microcap BioAtla, Inc. (NASDAQ: BCAB ) is a company I first covered back in May , highlighting the fresh air brought to their pipeline by the likes of Janux I have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space. Analyst's Di ...